Home > Insider Trading > Filing (0001179110-19-005747)

Filing Details

Accession Number:: 0001179110-19-005747
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-05-08 20:23:04
Reporting Period:: 2019-05-07

Accepted Time:: 2019-05-08 20:23:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651561	Tabula Rasa Healthcare Inc.	TRHC	Services-Business Services, Nec (7389)	465726437

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1685832	V Orsula Knowlton	228 Strawbridge Drive Suite 100 Moorestown NJ 08057	President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-05-07	3,741	$52.94	896,544	No	4	S	Indirect	Held by spouse.
Common Stock	Disposition	2019-05-07	3,529	$54.09	893,285	No	4	S	Indirect	Held by spouse.
Common Stock	Disposition	2019-05-07	1,000	$55.00	892,285	No	4	S	Indirect	Held by spouse.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by spouse.
No	4	S	Indirect	Held by spouse.
No	4	S	Indirect	Held by spouse.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	812,207	Direct
Common Stock	10,000	Indirect	Held by trust for children.
Common Stock	10,000	Indirect	Held by trust for children.

Footnotes

This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Calvin H. Knowlton on December 7, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $52.42 to $53.31, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $53.58 to $54.56, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $54.81 to $55.53, inclusive.
The reporting person received a restricted stock award of 267,268 shares of the Company's common stock on September 28, 2016. Pursuant to amendments to the restricted stock award on June 12, 2017 and May 30, 2018, respectively, 50% of such shares of common stock were scheduled to vest on May 31, 2019, with the remaining 50% of such shares of common stock scheduled to vest on January 31, 2020. Notwithstanding the foregoing, on May 2, 2019, the Company entered into an amendment to the restricted stock award with the reporting person and, pursuant thereto, all shares of common stock underlying such restricted stock award will now vest in six equal installments at the end of each calendar quarter beginning on June 30, 2019 and ending on September 30, 2020, such that the shares of common stock underlying such restricted stock award will be vested in full on September 30, 2020.